Company overview
Basic information
Company name
BALTMETICS, UAB
Company code
302464721
VAT code
LT100006278419
Registered address
Vilnius, Didlaukio g. 98-36, LT-08332
Registration date
2009-12-10
Company age: 16 y. 9 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Website
https://www.medikos.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
UAB "BALTMETICS"
Company code: 302464721
Address: Vilnius, Didlaukio g. 98-36, LT-08332
VAT code: LT100006278419
Download a detailed company report
Make confident decisions with all the information about BALTMETICS, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
BALTMETICS, UAB (company code 302464721) is an operational private limited liability company registered in 2009. It is a private business with Lithuanian ownership, classified among national private non-financial companies, and its governance is listed as CEO only. The company is a micro-sized enterprise and operates in retail sale of pharmaceutical products (EVRK code G.47.73.00). Its registered address is Didlaukio g. 98-36, Vilnius, Vilniaus m. municipality, Vilniaus county.
Financially, BALTMETICS generated EUR 489.4K in revenue in 2025, up 13.8% year on year and 26.6% over two years. Net profit reached EUR 26.8K, with a profit margin of 5.5%. Equity stood at EUR 73.2K, total assets at EUR 172.4K, and liabilities at EUR 99.2K. The latest reported ratios show return on equity of 36.6%, return on assets of 15.5%, equity ratio of 42.5%, debt to equity of 1.35, and asset turnover of 2.84x.
The company had an average of 1 employee in 2023, 2024 and 2025, while the average headcount increased to 2 so far in 2026.
Financially, BALTMETICS generated EUR 489.4K in revenue in 2025, up 13.8% year on year and 26.6% over two years. Net profit reached EUR 26.8K, with a profit margin of 5.5%. Equity stood at EUR 73.2K, total assets at EUR 172.4K, and liabilities at EUR 99.2K. The latest reported ratios show return on equity of 36.6%, return on assets of 15.5%, equity ratio of 42.5%, debt to equity of 1.35, and asset turnover of 2.84x.
The company had an average of 1 employee in 2023, 2024 and 2025, while the average headcount increased to 2 so far in 2026.